| Disease ID | Disease name | Source of annotation with TBP | OMIM link | Number of associated genes | genes |
|---|---|---|---|---|---|
| PS168600 | PARKINSON DISEASE | ClinVar, OMIM | link to OMIM | 30 | ATP13A2, FGF20, VPS13C, DNAJC13, ATXN2, PINK1, CHCHD2, ADH1C, UCHL1, GIGYF2, SYNJ1, PODXL, HTRA2, LRRK2, TBP, PARK2, ATXN8OS, SNCAIP, GBA, SNCA, NR4A2, PLA2G6, GLUD2, PARK7, ATXN3, MAPT, DNAJC6, EIF4G1, FBXO7, VPS35 |
| PS164400 | SPINOCEREBELLAR ATAXIA | ClinVar, OMIM | link to OMIM | 31 | PRKCG, ATXN2, SCYL1, PDYN, ELOVL5, ATXN10, TRPC3, ATXN8OS, NOP56, ATXN8, TBP, PPP2R2B, ELOVL4, PLEKHG4, ATXN7, AFG3L2, BEAN1, CACNA1A, ATXN1, TTBK2, KCND3, CACNA1G, TMEM240, ATXN3, KCNC3, SPTBN2, TGM6, CCDC88C, FGF14, ITPR1, EEF2 |
Download the gene annotation in CSV format
| KEGG pathway | KEGG ID | KEGG IC |
|---|---|---|
| Viral carcinogenesis | hsa05203 | 5.08 |
| Basal transcription factors | hsa03022 | 7.31 |
| Herpes simplex infection | hsa05168 | 5.08 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| Huntington's disease | hsa05016 | 5.17 |
| HTLV-I infection | hsa05166 | 4.59 |
| REACTOME pathway | REACTOME ID | REACTOME IC |
|---|---|---|
| Infectious disease | R-HSA-5663205 | 4.47 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.52 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.08 |
| RNA Polymerase I Chain Elongation | R-HSA-73777 | 7.18 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.52 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.28 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.75 |
| Disease | R-HSA-1643685 | 3.33 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.23 |
| Transcription of the HIV genome | R-HSA-167172 | 6.96 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.75 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.85 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.52 |
| Gene Expression | R-HSA-74160 | 2.72 |
| HIV Infection | R-HSA-162906 | 5.22 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.66 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.02 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.01 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.25 |
| SIRT1 negatively regulates rRNA Expression | R-HSA-427359 | 7.89 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.46 |
| RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription | R-HSA-504046 | 6.16 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.43 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.18 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.72 |
| HIV Transcription Initiation | R-HSA-167161 | 7.52 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.03 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.52 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.81 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.52 |
| HIV Life Cycle | R-HSA-162587 | 5.89 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.66 |
| GO term | GO ID | GO IC |
|---|---|---|
| core promoter sequence-specific DNA binding | GO:0001046 | 5.12 |
| RNA polymerase II regulatory region DNA binding | GO:0001012 | 3.36 |
| enzyme binding | GO:0019899 | 2.27 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| repressing transcription factor binding | GO:0070491 | 5.71 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| core promoter proximal region sequence-specific DNA binding | GO:0000987 | 3.83 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| transcription factor binding | GO:0008134 | 3.46 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| core promoter proximal region DNA binding | GO:0001159 | 3.82 |
| core promoter binding | GO:0001047 | 4.71 |
| RNA polymerase II repressing transcription factor binding | GO:0001103 | 6.44 |
| RNA polymerase II transcription factor binding | GO:0001085 | 5.08 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
| RNA polymerase II regulatory region sequence-specific DNA binding | GO:0000977 | 3.37 |
| protein binding | GO:0005515 | 0.46 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| RNA polymerase II core promoter proximal region sequence-specific DNA binding | GO:0000978 | 3.88 |
| RNA polymerase II core promoter sequence-specific DNA binding | GO:0000979 | 5.77 |
| binding | GO:0005488 | 0.18 |